Abstract
The development of India’s pharmaceutical industry has played a significant role in boosting the availability and affordability of pharmaceuticals. With significantly lower manufacturing costs relative to those in developed countries, Indian companies were able to lower the drug prices and increase access to medicines in India as well as in other low- and middle-income countries (LMICs). A number of policies introduced in the 1970s (discussed later in the chapter) underpinned this growth from a virtually non-existent pharmaceutical industry to becoming the world’s largest producer of generics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Copyright information
© 2010 Prabodh Malhotra
About this chapter
Cite this chapter
Malhotra, P. (2010). Development of India’s Pharmaceutical Industry. In: Impact of TRIPS in India. Palgrave Macmillan, London. https://doi.org/10.1057/9780230290747_4
Download citation
DOI: https://doi.org/10.1057/9780230290747_4
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-32348-7
Online ISBN: 978-0-230-29074-7
eBook Packages: Palgrave Economics & Finance CollectionEconomics and Finance (R0)